《藥物經(jīng)濟學與結(jié)果研究專家評論》(ISSN 1473-7167)提供有關藥物臨床使用和治療方法的成本效益和藥物經(jīng)濟學問題的專家評論。涵蓋范圍包括藥物經(jīng)濟學和生活質(zhì)量研究，治療結(jié)果，循證醫(yī)學和成本效益研究。所有的文章都要經(jīng)過嚴格的同行評審。該雜志采用獨特的專家評論文章格式，提供了一個關鍵技術領域、研究或臨床實踐的當前思想的完整概述，并輔以以下章節(jié):專家評論-對最有效或最有前途的策略的個人觀點五年展望——在一個現(xiàn)實的時間尺度內(nèi)對未來前景的清晰展望關鍵問題-執(zhí)行摘要削減到作者最關鍵的觀點

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points